AnalystsAndy ChenAndy Chen's Stock Forecasts
AnalystsAndy Chen
Sectors:
Industries:
Analyst Ranking
Top 17%
#879 out of 5208 analysts
Average Return
+41.63%
Win Rate
55%11 out of 20
Risk vs Reward
Poor
Good
Andy Chen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alpine Immune Sciences IncALPN | +546.47% | $10.05 | $64.97 | 2023-10-17 - 2024-05-17 | Strong Buy |
Insmed IncINSM | +175.86% | $28.75 | $79.31 | 2024-02-14 - 2025-02-14 | Buy |
Zenas Biopharma IncZBIO | +157.44% | $7.66 | $19.72 | 2025-02-03 - 2026-02-03 | Buy |
Oruka Therapeutics IncORKA | +143.14% | $14.21 | $34.55 | 2025-02-03 - 2026-02-03 | Buy |
Intellia Therapeutics IncNTLA | +71.78% | $7.92 | $13.61 | 2025-04-20 - 2026-03-03 | Buy |
Andy Chen Analyst Color
Get additional color on Andy Chen's coverage of popular stocks
Andy Chen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunovant IncIMVT | 2 | Buy | $50.00 | +87.20% | Upgrades | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 1 | Buy | $548.00 | +15.55% | Upgrades | 2 months ago |
Verona Pharma PLCVRNA | 1 | Buy | $170.00 | +59.01% | Initiates Coverage On | 8 months ago |
Bridgebio Pharma IncBBIO | 1 | Buy | $49.00 | -24.07% | Initiates Coverage On | 9 months ago |
Avidity Biosciences IncRNAM | 1 | Buy | $55.00 | +272.88% | Initiates Coverage On | 9 months ago |
Moonlake ImmunotherapeuticsMLTX | 1 | Buy | $61.00 | +244.83% | Upgrades | 9 months ago |
Intellia Therapeutics IncNTLA | 1 | Buy | $21.00 | +54.36% | Upgrades | 10 months ago |
Oruka Therapeutics IncORKA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | a year ago |
Vera Therapeutics IncVERA | 1 | Buy | $49.00 | N/A | Initiates Coverage On | a year ago |
Zenas Biopharma IncZBIO | 1 | Buy | $19.00 | N/A | Initiates Coverage On | a year ago |
Argenx SeARGX | 1 | Buy | $697.00 | N/A | Upgrades | a year ago |
Celldex Therapeutics IncCLDX | 1 | Buy | $51.00 | N/A | Reiterates | a year ago |
Kymera Therapeutics IncKYMR | 1 | Buy | $65.00 | N/A | Upgrades | 2 years ago |
Roivant Sciences LtdROIV | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 2 years ago |
Insmed IncINSM | 1 | Buy | $42.00 | N/A | Initiates Coverage On | 2 years ago |
Rapt Therapeutics IncRAPT | 2 | Buy | $312.00 | N/A | Initiates Coverage On | 2 years ago |
Alpine Immune Sciences IncALPN | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Affimed NvAFMDQ | 1 | Strong Buy | $60.00 | N/A | Assumes | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.